Skip to main content

Preemptive Low-Dose Norepinephrine Infusion for Reducing Hemodynamic Instability During Craniotomy for Brain Tumor Resection Under Propofol-Remifentanil Total Intravenous Anesthesia: A Randomized Controlled Trial

In brief

Preemptive low-dose norepinephrine drops rescue drug use to 17%

In a randomized trial of adults undergoing brain-tumor craniotomy under propofol-remifentanil anesthesia, a continuous low-dose norepinephrine infusion reduced moderate blood-pressure swings and cut the proportion needing any rescue vasopressor from 100% to about 17%, without increasing severe instability or complications. Larger studies are needed to confirm these hemodynamic benefits.

Journal
Journal of clinical medicine (Q1)
Published
29 June 2026
Study design
Randomized controlled trial
Evidence level
Level 1, High (CEBM 1b)
Authors
Kyeong Tae Min, Seung Ho Choi, Hyun Joo Kim, Bahn Lee, Seungyeon Lee, Hye Jin Kim
PMID
42452508
DOI
10.3390/jcm15135046

Why clinicians should know about it

  • Picked for Neurosurgery (top studies of the week, 19 July 2026): Preemptive norepinephrine reduces hemodynamic instability in craniotomy

Abstract

Background: Previous trials of prophylactic norepinephrine have compared it with volume loading or non-norepinephrine vasopressors. Thus, it remains unclear whether a preemptive norepinephrine strategy provides incremental benefit over conventional management permitting reactive norepinephrine use. We evaluated whether preemptive low-dose norepinephrine infusion reduces hemodynamic instability during craniotomy for brain tumor resection under propofol-remifentanil total intravenous anesthesia (TIVA). Methods: Adult patients undergoing craniotomy for brain tumor resection under propofol-remifentanil TIVA were randomized to preemptive continuous infusion of norepinephrine (CINE; started at 0.02 µg/kg/min and titrated to remain below 0.05 µg/kg/min) or conventional management, in which norepinephrine was administered at the anesthesiologist's discretion in response to hypotension. The primary endpoint was moderate or severe hemodynamic instability, defined as mean arterial pressure outside 80-120% and 70-130% of baseline, respectively. Secondary endpoints included rescue medication use, postoperative complications, and safety. Results: Compared with conventional management, the CINE group showed less moderate hemodynamic instability, both in the number of episodes per patient (median [interquartile range]: 6 [3-11] vs. 9 [5-13], p = 0.045) and in the proportion of anesthesia time affected (7.4% [3.6-12.4] vs. 12.2% [6.8-21.4], p = 0.017), but not less severe instability. Rescue medication was required less frequently in the CINE group (16.7% vs. 100%, p < 0.001). Complication rates were similar between the groups, and no adverse drug reactions occurred. Conclusions: Preemptive low-dose norepinephrine infusion reduced moderate hemodynamic instability during propofol-remifentanil TIVA for brain tumor resection, even against a control group receiving conventional management with reactive norepinephrine use, suggesting potential hemodynamic benefit that warrants confirmation in larger trials.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.